Vol. 9, Issue 3, Part G (2025)

Bacopa monnieri, a traditionally used medicinal herb, has garnered significant attention for its diverse phytochemistry and purported therapeutic benefits. This mini-review synthesizes current knowledge on the phytoconstituents of B. monnieri, focusing on the major bioactive compounds, including saponins (bacosides), and their chemical structures. We explore the established and emerging pharmacological activities of B. monnieri extracts and isolated compounds, emphasizing their neuroprotective, anxiolytic, nootropic, and anti-inflammatory properties. The review critically examines the evidence supporting these claims, highlighting gaps in the current research, such as inconsistencies across studies and the need for more rigorous clinical trials to determine optimal dosages and efficacy. Furthermore, we discuss the potential for developing standardized B. monnieri extracts with consistent bioactive compound profiles to ensure therapeutic reproducibility and efficacy. The review also concludes by summarizing the current understanding of B. monnieri's phytochemistry and medicinal potential, emphasizing the need for further research to fully elucidate its mechanisms of action and optimize its therapeutic applications.